Kuiz berkaitan panduan · Sederhana Tahap

FDA Clinical Decision Support Software Guidance Quiz

Tests FDA function-level analysis, intended users, independent reviewability, function distinctions, and current guidance checks.

soalan 1 daripada 8

Apakah yang dinilai oleh FDA dalam perisian sokongan keputusan klinikal?

Pratonton setiap soalan8 soalan

Jawapan dan penjelasan muncul semasa anda mengambil kuiz.

  1. Apakah yang dinilai oleh FDA dalam perisian sokongan keputusan klinikal?
    • The product’s “CDS” name alone
    • Only whether the model uses deep learning
    • The number of screens in the interface
    • The specific software function, intended use, user, and role in a decision
  2. Which condition is central to the non-device CDS exclusion for qualifying clinician-facing functions?
    • A health professional can independently review the basis for recommendations
    • The software gives a confidence score
    • A patient can change the display color
    • The output is stored in a cloud database
  3. Mengapa menganalisis fungsi produk mengikut fungsi?
    • The brand name defines each function
    • Function analysis is only for billing
    • One product may combine functions with different regulatory status
    • All functions inherit the same status automatically
  4. How may patient-facing software be assessed differently?
    • User identity has no relevance
    • The intended user differs from a health professional who can review the basis
    • Patients always have more access to model logic
    • All patient apps are exempt
  5. Does a generated explanation prove the recommendation’s basis?
    • Yes, any explanation is sufficient
    • Yes, if written in plain language
    • No recommendation can ever be reviewed
    • No; the explanation must reflect evidence the user can actually review
  6. Apakah yang perlu didokumenkan oleh pembangun untuk sesuatu fungsi?
    • Only a user interface video
    • A generic product description
    • Intended purpose, users, evidence, inputs, and reviewable basis
    • Only model size
  7. Why recheck the regulatory analysis after workflow changes?
    • Claims or outputs may change how the function is used
    • Workflow never affects intended use
    • Only the software code matters
    • Guidance is permanent and unchanging
  8. Apakah yang perlu dilakukan oleh doktor dengan cadangan CDS?
    • Treat it as a guaranteed diagnosis
    • Review the basis and apply clinical judgment
    • Follow it automatically because it is software
    • Ignore the patient context